• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于监测子宫内膜癌患者的液体活检:迈向个性化治疗

Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment.

作者信息

Piñeiro-Pérez Raquel, Abal Miguel, Muinelo-Romay Laura

机构信息

Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Trav. Choupana s/n, 15706 Santiago de Compostela, Spain.

Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Monforte de Lemos 3-5, 28029 Madrid, Spain.

出版信息

Cancers (Basel). 2022 Mar 9;14(6):1405. doi: 10.3390/cancers14061405.

DOI:10.3390/cancers14061405
PMID:35326558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8946652/
Abstract

Endometrial cancer (EC) is the most frequent gynecological cancer in developed countries and its incidence shows an increasing trend. Fortunately, the prognosis of the disease is good when the tumour is diagnosed in an early phase, but some patients recur after surgery and develop distant metastasis. The therapy options for EC for advanced disease are more limited than for other tumours. Therefore, the application of non-invasive strategies to anticipate the recurrence of localized tumours and guide the treatment in advanced stages represents a clear requirement to improve the survival and quality of life of patients with EC. To achieve this desired precision oncology, it is necessary to invest in the identification and validation of circulating markers that allow a more effective stratification and monitoring of patients. We here review the main advances made for the evaluation of circulating tumour DNA (ctDNA), circulating tumour cells (CTCs), circulating extracellular vesicles (cEVs), and other non-invasive biomarkers as a monitoring tool in the context of localized and advanced endometrial tumours, with the aim of providing a global perspective of the achievements and the key areas in which the use of these markers can be developed into a real clinical tool.

摘要

子宫内膜癌(EC)是发达国家最常见的妇科癌症,其发病率呈上升趋势。幸运的是,若肿瘤在早期被诊断,该疾病的预后良好,但一些患者术后会复发并发生远处转移。与其他肿瘤相比,晚期EC的治疗选择更为有限。因此,应用非侵入性策略来预测局部肿瘤的复发并指导晚期治疗,显然是提高EC患者生存率和生活质量的必要条件。为了实现这种理想的精准肿瘤学,有必要投入精力识别和验证循环标志物,以便更有效地对患者进行分层和监测。在此,我们综述了在局部和晚期子宫内膜肿瘤背景下,作为监测工具评估循环肿瘤DNA(ctDNA)、循环肿瘤细胞(CTC)、循环细胞外囊泡(cEV)及其他非侵入性生物标志物方面取得的主要进展,旨在全面了解这些标志物的研究成果以及可将其应用发展为实际临床工具的关键领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b0/8946652/49c38bff6aa6/cancers-14-01405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b0/8946652/49c38bff6aa6/cancers-14-01405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b0/8946652/49c38bff6aa6/cancers-14-01405-g001.jpg

相似文献

1
Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment.用于监测子宫内膜癌患者的液体活检:迈向个性化治疗
Cancers (Basel). 2022 Mar 9;14(6):1405. doi: 10.3390/cancers14061405.
2
Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.液体活检在子宫内膜癌中的应用:肿瘤个体化治疗的新机遇。
Int J Mol Sci. 2018 Aug 7;19(8):2311. doi: 10.3390/ijms19082311.
3
Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update.循环肿瘤细胞和循环肿瘤DNA在非小细胞肺癌中的临床应用——最新进展
Front Oncol. 2022 Mar 15;12:859152. doi: 10.3389/fonc.2022.859152. eCollection 2022.
4
Methods for the Detection of Circulating Biomarkers in Cancer Patients.癌症患者循环生物标志物的检测方法。
Adv Exp Med Biol. 2022;1379:525-552. doi: 10.1007/978-3-031-04039-9_21.
5
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer.循环游离DNA或循环肿瘤DNA在卵巢癌和子宫内膜癌管理中的应用
Onco Targets Ther. 2019 Dec 27;12:11517-11530. doi: 10.2147/OTT.S227156. eCollection 2019.
6
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.基于血液的液体活检在前列腺癌中的临床决策中的定量和定性分析。
Eur Urol. 2021 Jun;79(6):762-771. doi: 10.1016/j.eururo.2020.12.037. Epub 2021 Jan 7.
7
Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma.循环肿瘤DNA在胰腺腺癌中的临床应用
J Pers Med. 2019 Jul 18;9(3):37. doi: 10.3390/jpm9030037.
8
Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.循环肿瘤 DNA 改变:头颈部鳞状细胞癌的新兴生物标志物。
J Biomed Sci. 2023 Aug 9;30(1):65. doi: 10.1186/s12929-023-00953-z.
9
Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.液体活检在肝癌个体化医学中的基因组图谱
Cancer Genomics Proteomics. 2021 May-Jun;18(3 Suppl):369-383. doi: 10.21873/cgp.20266. Epub 2021 May 15.
10
Clinical application of liquid biopsy in endometrial carcinoma.液体活检在子宫内膜癌中的临床应用。
Med Oncol. 2023 Feb 9;40(3):92. doi: 10.1007/s12032-023-01956-4.

引用本文的文献

1
Beyond the Microscope: Integrating Liquid Biopsies into the Molecular Pathology Era of Endometrial Cancer.超越显微镜:将液体活检纳入子宫内膜癌分子病理学时代
Int J Mol Sci. 2025 Aug 19;26(16):7987. doi: 10.3390/ijms26167987.
2
Advances and challenges in the use of liquid biopsy in gynaecological oncology.液体活检在妇科肿瘤学中的应用进展与挑战
Heliyon. 2024 Oct 15;10(20):e39148. doi: 10.1016/j.heliyon.2024.e39148. eCollection 2024 Oct 30.
3
RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer.

本文引用的文献

1
Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis.患者来源的类器官反映子宫内膜肿瘤的基因特征并预测患者预后。
Commun Med (Lond). 2021 Jul 30;1:20. doi: 10.1038/s43856-021-00019-x. eCollection 2021.
2
HE4 as a Biomarker for Endometrial Cancer.人附睾蛋白4作为子宫内膜癌的生物标志物
Cancers (Basel). 2021 Sep 23;13(19):4764. doi: 10.3390/cancers13194764.
3
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab.
RNA 5-甲基胞嘧啶调节剂与细胞黏附相关,并可预测子宫内膜癌的预后。
Transl Cancer Res. 2023 Oct 31;12(10):2556-2571. doi: 10.21037/tcr-23-742. Epub 2023 Oct 24.
4
Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.循环肿瘤细胞(CTCs)和循环肿瘤DNA(ctDNA)的分离、表征及分析新策略的进展
Ther Adv Med Oncol. 2023 Sep 7;15:17588359231192401. doi: 10.1177/17588359231192401. eCollection 2023.
5
Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.基于蛋白质组学、代谢组学和临床数据的子宫内膜癌诊断与预后算法:一项系统综述
Front Oncol. 2023 Apr 6;13:1120178. doi: 10.3389/fonc.2023.1120178. eCollection 2023.
6
Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report.通过液体活检分析改善子宫内膜癌患者的管理:病例报告。
Int J Mol Sci. 2022 Aug 1;23(15):8539. doi: 10.3390/ijms23158539.
帕博利珠单抗治疗转移性非小细胞肺癌患者的循环游离 DNA 和循环肿瘤细胞的临床潜力。
Mol Oncol. 2021 Nov;15(11):2923-2940. doi: 10.1002/1878-0261.13094. Epub 2021 Sep 23.
4
Two Dimensional-Difference in Gel Electrophoresis (2D-DIGE) Proteomic Approach for the Identification of Biomarkers in Endometrial Cancer Serum.二维差异凝胶电泳(2D-DIGE)蛋白质组学方法用于鉴定子宫内膜癌血清中的生物标志物
Cancers (Basel). 2021 Jul 20;13(14):3639. doi: 10.3390/cancers13143639.
5
Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing.成功建立用于疾病建模和药物敏感性测试的妇科癌症患者来源类器官培养体系。
Cancers (Basel). 2021 Jun 10;13(12):2901. doi: 10.3390/cancers13122901.
6
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.基于更新后的ESGO/ESTRO/ESP指南看子宫内膜癌的新病理及临床见解
Cancers (Basel). 2021 May 26;13(11):2623. doi: 10.3390/cancers13112623.
7
A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients.循环游离DNA动态监测转移性乳腺癌患者治疗反应的系统评价
Cancers (Basel). 2021 Apr 10;13(8):1811. doi: 10.3390/cancers13081811.
8
Three plasma-based microRNAs as potent diagnostic biomarkers for endometrial cancer.三种基于血浆的 microRNAs 作为子宫内膜癌的有效诊断生物标志物。
Cancer Biomark. 2021;31(2):127-138. doi: 10.3233/CBM-200972.
9
Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.血浆衍生的外泌体 miR-15a-5p 作为一种有前途的诊断生物标志物,可用于早期检测子宫内膜癌。
Mol Cancer. 2021 Mar 29;20(1):57. doi: 10.1186/s12943-021-01352-4.
10
Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.TCGA 分类和 SWI/SNF 蛋白表达在未分化/去分化子宫内膜癌中的临床病理意义:一种可能的预后风险分层。
Gynecol Oncol. 2021 May;161(2):629-635. doi: 10.1016/j.ygyno.2021.02.029. Epub 2021 Mar 10.